These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Iron-overload and genotypic expression of HFE mutations H63D/C282Y and transferrin receptor Hin6I and BanI polymorphism in german patients with hereditary haemochromatosis. Gottschalk R; Seidl C; Schilling S; Braner A; Seifried E; Hoelzer D; Kaltwasser JP Eur J Immunogenet; 2000 Jun; 27(3):129-34. PubMed ID: 10940080 [TBL] [Abstract][Full Text] [Related]
23. Blunted increase in serum hepcidin as response to oral iron in HFE-hemochromatosis. Sangwaiya A; Manglam V; Busbridge M; Thursz M; Arnold J Eur J Gastroenterol Hepatol; 2011 Aug; 23(8):721-4. PubMed ID: 21654321 [TBL] [Abstract][Full Text] [Related]
24. [Study on HFE gene mutations in patients with myelodysplastic syndromes and aplastic anemia]. Nie L; Ai XF; Zheng YZ; Li QH; Yang L; Xiao ZJ Zhonghua Xue Ye Xue Za Zhi; 2009 Apr; 30(4):223-8. PubMed ID: 19731820 [TBL] [Abstract][Full Text] [Related]
25. The hepcidin gene promoter nc.-1010C > T; -582A > G haplotype modulates serum ferritin in individuals carrying the common H63D mutation in HFE gene. Silva B; Pita L; Gomes S; Gonçalves J; Faustino P Ann Hematol; 2014 Dec; 93(12):2063-6. PubMed ID: 25015054 [TBL] [Abstract][Full Text] [Related]
26. Genotype screening for hereditary hemochromatosis among voluntary blood donors in Hungary. Andrikovics H; Kalmár L; Bors A; Fandl B; Petri I; Kalász L; Tordai A Blood Cells Mol Dis; 2001; 27(1):334-41. PubMed ID: 11358395 [TBL] [Abstract][Full Text] [Related]
27. HFE genotypes in decompensated alcoholic liver disease: phenotypic expression and comparison with heavy drinking and with normal controls. Gleeson D; Evans S; Bradley M; Jones J; Peck RJ; Dube A; Rigby E; Dalton A Am J Gastroenterol; 2006 Feb; 101(2):304-10. PubMed ID: 16454835 [TBL] [Abstract][Full Text] [Related]
28. HFE mutations modulate the effect of iron on serum hepcidin-25 in chronic hemodialysis patients. Valenti L; Girelli D; Valenti GF; Castagna A; Como G; Campostrini N; Rametta R; Dongiovanni P; Messa P; Fargion S Clin J Am Soc Nephrol; 2009 Aug; 4(8):1331-7. PubMed ID: 19541813 [TBL] [Abstract][Full Text] [Related]
29. Immunohistochemistry of the Hfe protein in patients with hereditary hemochromatosis, iron deficiency anemia, and normal controls. Byrnes V; Ryan E; O'Keane C; Crowe J Blood Cells Mol Dis; 2000 Feb; 26(1):2-8. PubMed ID: 10772870 [TBL] [Abstract][Full Text] [Related]
30. Regulation of iron absorption in Hfe mutant mice. Ajioka RS; Levy JE; Andrews NC; Kushner JP Blood; 2002 Aug; 100(4):1465-9. PubMed ID: 12149232 [TBL] [Abstract][Full Text] [Related]
31. Examining the clinical use of hemochromatosis genetic testing. Lanktree MB; Lanktree BB; Paré G; Waye JS; Sadikovic B; Crowther MA Can J Gastroenterol Hepatol; 2015; 29(1):41-5. PubMed ID: 25706573 [TBL] [Abstract][Full Text] [Related]
32. Iron overload and HFE gene mutations in Czech patients with chronic liver diseases. Dostalikova-Cimburova M; Kratka K; Stransky J; Putova I; Cieslarova B; Horak J Dis Markers; 2012; 32(1):65-72. PubMed ID: 22297603 [TBL] [Abstract][Full Text] [Related]
33. Clinical relevance of hemochromatosis-related HFE C282Y/H63D gene mutations in patients on chronic dialysis. Canavese C; Bergamo D; Barbieri S; Timbaldi M; Thea A; Martina G; Damiani D; Fenoglio R; Donati-Marella B; Priolo G Clin Nephrol; 2002 Dec; 58(6):438-44. PubMed ID: 12508966 [TBL] [Abstract][Full Text] [Related]
34. Ethnic and genetic factors of iron status in women of reproductive age. Gordeuk VR; Brannon PM Am J Clin Nutr; 2017 Dec; 106(Suppl 6):1594S-1599S. PubMed ID: 29070555 [No Abstract] [Full Text] [Related]
35. Prevalence of coronary heart disease associated with HFE mutations in adults attending a health appraisal center. Waalen J; Felitti V; Gelbart T; Ho NJ; Beutler E Am J Med; 2002 Oct; 113(6):472-9. PubMed ID: 12427496 [TBL] [Abstract][Full Text] [Related]
36. Prevalence, characteristics, and prognostic significance of HFE gene mutations in type 2 diabetes: the Fremantle Diabetes Study. Davis TM; Beilby J; Davis WA; Olynyk JK; Jeffrey GP; Rossi E; Boyder C; Bruce DG Diabetes Care; 2008 Sep; 31(9):1795-801. PubMed ID: 18566337 [TBL] [Abstract][Full Text] [Related]
37. Screening selected blood donors with biochemical iron overload for hemochromatosis: a regional experience. De Gobbi M; D'Antico S; Castagno F; Testa D; Merlini R; Bondi A; Camaschella C Haematologica; 2004 Oct; 89(10):1161-7. PubMed ID: 15477198 [TBL] [Abstract][Full Text] [Related]
38. Hemochromatosis gene mutations and iron metabolism in celiac disease. Barisani D; Ceroni S; Del Bianco S; Meneveri R; Bardella MT Haematologica; 2004 Nov; 89(11):1299-305. PubMed ID: 15531451 [TBL] [Abstract][Full Text] [Related]
39. Frequency of HFE mutations among Turkish blood donors according to transferrin saturation: genotype screening for hereditary hemochromatosis among voluntary blood donors in Turkey. Simsek H; Sumer H; Yilmaz E; Balaban YH; Ozcebe O; Hascelik G; Buyukask Y; Tatar G J Clin Gastroenterol; 2004 Sep; 38(8):671-5. PubMed ID: 15319650 [TBL] [Abstract][Full Text] [Related]
40. Testing for haemochromatosis in a liver clinic population: relationship between ethnic origin, HFE gene mutations, liver histology and serum iron markers. Moodie SJ; Ang L; Stenner JM; Finlayson C; Khotari A; Levin GE; Maxwell JD Eur J Gastroenterol Hepatol; 2002 Mar; 14(3):223-9. PubMed ID: 11953685 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]